EUVIMEDEUVIMED entdecken
Crossref

Cognitive Potentially Inappropriate Medications, Quality of Life, and Healthcare Use in Older Adults With Cognitive Disorders

Kognitive potenziell inadäquate Medikamente, Lebensqualität und Gesundheitsversorgung bei älteren Erwachsenen mit kognitiven Störungen

Haowen Hsu iD, Collin M Clark iD, Steven Feuerstein, Robert G Wahler, Ranjit Singh, David M Jacobs iD

Journal of the American Geriatrics Society · 2026-10 · 74 (10) · 2888-2897

DOI: 10.1111/jgs.70607 ↗

Auf einen Blick

Bei älteren Erwachsenen mit kognitiven Störungen war die Exposition gegenüber CogPIMs häufig und nahm von 2011 bis 2022 ab. Sie war mit schlechterer mentaler Lebensqualität und mehr Akutversorgung verbunden.

Fragestellung

Wie sind CogPIMs bei älteren Erwachsenen mit kognitiven Störungen mit HRQoL und Gesundheitsversorgung verbunden?

Methode

Querschnittsanalyse von MEPS-Daten 2011–2022 bei Erwachsenen ≥ 65 Jahren mit kognitiven Störungen; Gewichtung und Regressionsmodelle zur Adjustierung von Confoundern.

Ergebnisse

2.796 ältere Erwachsene; gewichtet 29,7 Millionen. CogPIM-Exposition: 39,3 % in 2011 vs. 29,3 % in 2022; APC −1,9 %; p < 0,01. Mental HRQoL schlechter: aOR 1,72 (95 %-KI 1,31–2,25). ED-Besuche: aIRR 1,41 (1,24–1,60); Hospitalisierungen: aIRR 1,38 (1,19–1,59).

Schlussfolgerung der Autor:innen

Unter community-dwelling älteren Erwachsenen mit kognitiven Störungen war die CogPIM-Exposition häufig und mit schlechterer mentaler HRQoL sowie mehr Akutversorgung verbunden. Längsschnitt- und Interventionsstudien sind nötig.

Kernaussagen

  • CogPIM-Exposition nahm von 39,3 % auf 29,3 % ab
  • Verknüpft mit schlechterer mentaler HRQoL: aOR 1,72
  • Mehr ED-Besuche und Hospitalisierungen, nicht mehr ambulante Besuche

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 04.08.2026. Verfasst von Haowen Hsu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Quality of Life, Cognition Disorders, Patient Acceptance of Health Care, Inappropriate Prescribing. Die Arbeit nennt 49 Literaturangaben. Gefördert von: NCATS NIH HHS, AHRQ HHS, NHLBI NIH HHS.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Older adults with cognitive disorders, including dementia and mild cognitive impairment, are particularly vulnerable to adverse effects from centrally acting medications. Cognitive potentially inappropriate medications (CogPIMs), including anticholinergics, antipsychotics, benzodiazepines (BZDs), and non‐benzodiazepine hypnotics (Z‐drugs), may worsen well‐being and increase healthcare utilization in this population. This study evaluates CogPIMs exposure and its association with health‐related quality of life (HRQoL) and healthcare utilization among community‐dwelling older adults with cognitive disorders.

Methods

We conducted a cross‐sectional analysis of 2011–2022 Medical Expenditure Panel Survey (MEPS) data from adults aged ≥ 65 with cognitive disorders. CogPIMs exposure was defined as ≥ 1 prescription of anticholinergics, antipsychotics, BZDs, or Z‐drugs. Outcomes included (1) annual prevalence of CogPIMs exposure, (2) healthcare utilization, and (3) HRQoL measured by SF‐12 physical and mental component scores. Inverse probability of treatment weighting was used to adjust for confounding. Temporal trends were assessed using Joinpoint regression. Survey‐weighted logistic and negative binomial regression models estimated adjusted associations.

Results

A total of 2796 older adults with cognitive disorders were identified in MEPS from 2011 to 2022, representing a weighted analytic sample of 29.7 million individuals. Overall CogPIM exposure declined from 39.3% in 2011 to 29.3% in 2022 (Annual Percentage Change: −1.9%, p < 0.01). CogPIM exposure was not associated with poor physical HRQoL but was associated with higher odds of poor mental HRQoL (adjusted Odds Ratio: 1.72 [1.31–2.25], p < 0.01). CogPIM exposure was also associated with higher rates of emergency department visits (adjusted incidence rate ratios (aIRR) = 1.41 [1.24–1.60], p < 0.01) and hospitalizations (aIRR = 1.38 [1.19–1.59], p < 0.01), but not outpatient visits (aIRR = 1.27 [0.75–1.54], p = 0.31).

Conclusions

Among community‐dwelling older adults with cognitive disorders, CogPIM exposure remains common and is associated with poorer mental HRQoL and increased acute care utilization. Future longitudinal and interventional studies are needed to determine whether modifying exposure to CogPIM can improve well‐being and reduce potentially preventable acute care utilization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeCognition DisordersPatient Acceptance of Health CareInappropriate PrescribingPotentially Inappropriate Medication ListHumansAgedCross-Sectional StudiesFemaleMaleAged, 80 and overUnited StatesAntipsychotic AgentsCognitive DysfunctionBenzodiazepines

Stichwörter der Autor:innen

cognitive disordershealthcare utilizationhealthcare‐related quality of lifemedical expenditure panel surveypotentially inappropriate medications

Substanzen

Antipsychotic AgentsBenzodiazepines

Autor:innen und Institutionen

  • Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Department of Family Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.

ORCID-Profile: Haowen Hsu, Collin M Clark, David M Jacobs

Förderung

  • NCATS NIH HHS
  • AHRQ HHS
  • NHLBI NIH HHS
  • National Center for Advancing Translational Sciences
  • Agency for Healthcare Research and Quality
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Hsu, H., Clark, C. M., Feuerstein, S., Wahler, R. G., Singh, R., & Jacobs, D. M. (2026). Cognitive Potentially Inappropriate Medications, Quality of Life, and Healthcare Use in Older Adults With Cognitive Disorders. Journal of the American Geriatrics Society, 74(10), 2888-2897. https://doi.org/10.1111/jgs.70607

Vancouver

Hsu H, Clark CM, Feuerstein S, Wahler RG, Singh R, Jacobs DM. Cognitive Potentially Inappropriate Medications, Quality of Life, and Healthcare Use in Older Adults With Cognitive Disorders. Journal of the American Geriatrics Society. 2026;74(10):2888-2897. doi:10.1111/jgs.70607

BibTeX
@article{Hsu2026,
  author = {Hsu, Haowen and Clark, Collin M and Feuerstein, Steven and Wahler, Robert G and Singh, Ranjit and Jacobs, David M},
  title = {Cognitive Potentially Inappropriate Medications, Quality of Life, and Healthcare Use in Older Adults With Cognitive Disorders},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  volume = {74},
  number = {10},
  pages = {2888--2897},
  doi = {10.1111/jgs.70607}
}
Kostenlos starten →